Delaware | 52-1492296 | |||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
78 SW 7th Street, Suite 900 | Miami, | Florida | 33130 | |||||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common stock, par value $0.004 per share | LAUR | The NASDAQ Stock Market LLC | ||||||
Nasdaq Global Select Market |
Class | Outstanding at March 31, 2022 | |||||||
Common stock, par value $0.004 per share | 172,504,981 shares |
INDEX | ||||||||
PART I. - FINANCIAL INFORMATION | Page No. | |||||||
Item 1. | Financial Statements (Unaudited) | |||||||
Consolidated Statements of Operations - Three months ended March 31, 2022 and March 31, 2021 | ||||||||
Consolidated Statements of Comprehensive Income - Three months ended March 31, 2022 and March 31, 2021 | ||||||||
Consolidated Balance Sheets - March 31, 2022 and December 31, 2021 | ||||||||
Consolidated Statements of Cash Flows - Three months ended March 31, 2022 and March 31, 2021 | ||||||||
Notes to Consolidated Financial Statements | ||||||||
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | |||||||
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | |||||||
Item 4. | Controls and Procedures | |||||||
PART II. - OTHER INFORMATION | ||||||||
Item 1. | Legal Proceedings | |||||||
Item 1A. | Risk Factors | |||||||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | |||||||
Item 6. | Exhibits | |||||||
SIGNATURES | ||||||||
For the three months ended March 31, | 2022 | 2021 | |||||||||
(Unaudited) | (Unaudited) | ||||||||||
Revenues | $ | 209,563 | $ | 194,701 | |||||||
Costs and expenses: | |||||||||||
Direct costs | 182,880 | 181,848 | |||||||||
General and administrative expenses | 17,505 | 42,594 | |||||||||
Loss on impairment of assets | 144 | 56,650 | |||||||||
Operating income (loss) | 9,034 | (86,391) | |||||||||
Interest income | 1,968 | 711 | |||||||||
Interest expense | (3,731) | (23,518) | |||||||||
Loss on debt extinguishment | — | (13) | |||||||||
Gain on derivatives | — | 29,330 | |||||||||
Other (expense) income, net | (1,226) | 34 | |||||||||
Foreign currency exchange (loss) gain, net | (3,601) | 28,183 | |||||||||
Income (loss) from continuing operations before income taxes and equity in net income of affiliates | 2,444 | (51,664) | |||||||||
Income tax expense | (47,967) | (112,861) | |||||||||
Equity in net income of affiliates, net of tax | 108 | — | |||||||||
Loss from continuing operations | (45,415) | (164,525) | |||||||||
Income (loss) from discontinued operations, net of tax expense of $0 and $9,665, respectively | 735 | (418) | |||||||||
Net loss | (44,680) | (164,943) | |||||||||
Net loss attributable to noncontrolling interests | 469 | 15 | |||||||||
Net loss attributable to Laureate Education, Inc. | $ | (44,211) | $ | (164,928) | |||||||
Basic and diluted earnings (loss) per share: | |||||||||||
Loss from continuing operations | $ | (0.25) | $ | (0.82) | |||||||
Income (loss) from discontinued operations | — | — | |||||||||
Basic and diluted loss per share | $ | (0.25) | $ | (0.82) | |||||||
For the three months ended March 31, | 2022 | 2021 | |||||||||
(Unaudited) | (Unaudited) | ||||||||||
Net loss | $ | (44,680) | $ | (164,943) | |||||||
Other comprehensive income (loss): | |||||||||||
Foreign currency translation adjustment, net of tax of $0 for both periods | 49,575 | (59,761) | |||||||||
Minimum pension liability adjustment, net of tax of $0 for both periods | 14 | (168) | |||||||||
Total other comprehensive income (loss) | 49,589 | (59,929) | |||||||||
Comprehensive income (loss) | 4,909 | (224,872) | |||||||||
Net comprehensive loss attributable to noncontrolling interests | 467 | 33 | |||||||||
Comprehensive income (loss) attributable to Laureate Education, Inc. | $ | 5,376 | $ | (224,839) |
March 31, 2022 | December 31, 2021 | ||||||||||
Assets | (Unaudited) | ||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 293,835 | $ | 324,801 | |||||||
Restricted cash | 20,607 | 20,774 | |||||||||
Receivables: | |||||||||||
Accounts and notes receivable | 108,851 | 117,987 | |||||||||
Other receivables | 80,690 | 96,229 | |||||||||
Allowance for doubtful accounts | (60,461) | (62,226) | |||||||||
Receivables, net | 129,080 | 151,990 | |||||||||
Income tax receivable | 27,055 | 30,474 | |||||||||
Prepaid expenses and other current assets | 21,034 | 16,280 | |||||||||
Total current assets | 491,611 | 544,319 | |||||||||
Property and equipment: | |||||||||||
Land | 127,695 | 121,173 | |||||||||
Buildings | 346,870 | 328,343 | |||||||||
Furniture, equipment and software | 478,945 | 459,189 | |||||||||
Leasehold improvements | 113,034 | 106,813 | |||||||||
Construction in-progress | 8,902 | 9,622 | |||||||||
Accumulated depreciation and amortization | (558,593) | (525,623) | |||||||||
Property and equipment, net | 516,853 | 499,517 | |||||||||
Operating lease right-of-use assets, net | 384,496 | 384,344 | |||||||||
Goodwill | 567,061 | 546,795 | |||||||||
Tradenames | 148,646 | 142,848 | |||||||||
Deferred costs, net | 5,903 | 5,981 | |||||||||
Deferred income taxes | 47,782 | 38,713 | |||||||||
Other assets | 41,807 | 42,629 | |||||||||
Long-term assets held for sale | 6,573 | 6,164 | |||||||||
Total assets | $ | 2,210,732 | $ | 2,211,310 |
March 31, 2022 | December 31, 2021 | ||||||||||
Liabilities and stockholders' equity | (Unaudited) | ||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 45,704 | $ | 26,870 | |||||||
Accrued expenses | 72,190 | 65,558 | |||||||||
Accrued compensation and benefits | 68,677 | 90,454 | |||||||||
Deferred revenue and student deposits | 97,055 | 43,959 | |||||||||
Current portion of operating leases | 39,281 | 38,149 | |||||||||
Current portion of long-term debt and finance leases | 53,220 | 49,082 | |||||||||
Income taxes payable | 32,348 | 38,705 | |||||||||
Other current liabilities | 16,891 | 18,097 | |||||||||
Current liabilities held for sale | 1,167 | 1,054 | |||||||||
Total current liabilities | 426,533 | 371,928 | |||||||||
Long-term operating leases, less current portion | 373,557 | 377,104 | |||||||||
Long-term debt and finance leases, less current portion | 99,425 | 104,588 | |||||||||
Deferred compensation | 11,971 | 11,896 | |||||||||
Income taxes payable | 128,800 | 96,463 | |||||||||
Deferred income taxes | 88,361 | 73,624 | |||||||||
Other long-term liabilities | 24,987 | 24,640 | |||||||||
Long-term liabilities held for sale | 10,496 | 9,795 | |||||||||
Total liabilities | 1,164,130 | 1,070,038 | |||||||||
Redeemable noncontrolling interests and equity | 1,714 | 1,714 | |||||||||
Stockholders' equity: | |||||||||||
Preferred stock, par value $0.001 per share – 50,000 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021 | — | — | |||||||||
Common stock, par value $0.004 per share – 700,000 shares authorized, 230,210 shares issued and 172,505 shares outstanding as of March 31, 2022 and 228,831 shares issued and 180,611 shares outstanding as of December 31, 2021 | 921 | 915 | |||||||||
Additional paid-in capital | 2,402,072 | 2,388,783 | |||||||||
(Accumulated deficit) retained earnings | (28,688) | 15,523 | |||||||||
Accumulated other comprehensive loss | (470,617) | (520,204) | |||||||||
Treasury stock at cost (57,705 shares held at March 31, 2022 and 48,220 shares held at December 31, 2021) | (857,048) | (744,174) | |||||||||
Total Laureate Education, Inc. stockholders' equity | 1,046,640 | 1,140,843 | |||||||||
Noncontrolling interests | (1,752) | (1,285) | |||||||||
Total stockholders' equity | 1,044,888 | 1,139,558 | |||||||||
Total liabilities and stockholders' equity | $ | 2,210,732 | $ | 2,211,310 |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Cash flows from operating activities | (Unaudited) | (Unaudited) | |||||||||
Net loss | $ | (44,680) | $ | (164,943) | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | 14,365 | 22,672 | |||||||||
Amortization of operating lease right-of-use assets | 7,763 | 15,688 | |||||||||
Loss on impairment of assets | 144 | 57,714 | |||||||||
(Gain) loss on sales and disposal of subsidiaries and property and equipment, net | (713) | 16,461 | |||||||||
Gain on derivative instruments | — | (29,330) | |||||||||
Loss on debt extinguishment | — | 73 | |||||||||
Non-cash interest expense | 234 | 4,592 | |||||||||
Non-cash share-based compensation expense | 2,762 | 1,576 | |||||||||
Bad debt expense | (2,535) | 3,273 | |||||||||
Deferred income taxes | 4,413 | 84,409 | |||||||||
Unrealized foreign currency exchange gain | (753) | (23,687) | |||||||||
Non-cash loss from non-income tax contingencies | 69 | 11,995 | |||||||||
Other, net | 1,563 | 1,909 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Receivables | 18,922 | 5,111 | |||||||||
Prepaid expenses and other assets | (2,996) | (14,133) | |||||||||
Accounts payable and accrued expenses | (15,695) | (30,733) | |||||||||
Income tax receivable/payable, net | 26,960 | (16,731) | |||||||||
Deferred revenue and other liabilities | 44,054 | 65,367 | |||||||||
Net cash provided by operating activities | 53,877 | 11,283 | |||||||||
Cash flows from investing activities | |||||||||||
Purchase of property and equipment | (1,211) | (11,743) | |||||||||
Expenditures for deferred costs | (44) | (1,896) | |||||||||
Receipts from sales of discontinued operations, net of cash sold, and property and equipment | 9,193 | 30,845 | |||||||||
Payments on derivatives related to sale of discontinued operations | — | (18,294) | |||||||||
Net cash provided by (used in) investing activities | 7,938 | (1,088) | |||||||||
Cash flows from financing activities | |||||||||||
Proceeds from issuance of long-term debt, net of original issue discount | 49,691 | 996 | |||||||||
Payments on long-term debt | (58,890) | (53,670) | |||||||||
Payment of dividend equivalent rights for vested share-based awards | (3,490) | — | |||||||||
Proceeds from exercise of stock options | 11,496 | — | |||||||||
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options | (774) | (1,222) | |||||||||
Payments to repurchase common stock | (102,171) | (145,244) | |||||||||
Payments of debt issuance costs | — | (14) | |||||||||
Net cash used in financing activities | (104,138) | (199,154) | |||||||||
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash | 11,190 | (6,850) | |||||||||
Change in cash included in current assets held for sale | — | (3,526) | |||||||||
Net change in Cash and cash equivalents and Restricted cash | (31,133) | (199,335) | |||||||||
Cash and cash equivalents and Restricted cash at beginning of period | 345,575 | 867,298 | |||||||||
Cash and cash equivalents and Restricted cash at end of period | $ | 314,442 | $ | 667,963 |
Mexico | Peru | Corporate(1) | Total | ||||||||||||||
2022 | |||||||||||||||||
Tuition and educational services | $ | 174,074 | $ | 56,519 | $ | — | $ | 230,593 | 110 | % | |||||||
Other | 28,616 | 13,387 | 1,610 | 43,613 | 21 | % | |||||||||||
Gross revenue | 202,690 | 69,906 | 1,610 | 274,206 | 131 | % | |||||||||||
Less: Discounts / waivers / scholarships | (60,141) | (4,502) | — | (64,643) | (31) | % | |||||||||||
Total | $ | 142,549 | $ | 65,404 | $ | 1,610 | $ | 209,563 | 100 | % | |||||||
2021 | |||||||||||||||||
Tuition and educational services | $ | 166,024 | $ | 51,452 | $ | — | $ | 217,476 | 112 | % | |||||||
Other | 23,522 | 9,583 | 1,806 | 34,911 | 18 | % | |||||||||||
Gross revenue | 189,546 | 61,035 | 1,806 | 252,387 | 130 | % | |||||||||||
Less: Discounts / waivers / scholarships | (54,149) | (3,537) | — | (57,686) | (30) | % | |||||||||||
Total | $ | 135,397 | $ | 57,498 | $ | 1,806 | $ | 194,701 | 100 | % |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Revenues | $ | — | $ | 239,750 | |||||||
Share-based compensation expense | — | (242) | |||||||||
Other direct costs | — | (201,197) | |||||||||
Loss on impairment of assets | — | (1,064) | |||||||||
Other non-operating expense | — | (11,163) | |||||||||
Gain (loss) on sale of discontinued operations before taxes, net | 735 | (16,837) | |||||||||
Pretax income (loss) of discontinued operations | 735 | 9,247 | |||||||||
Income tax expense | — | (9,665) | |||||||||
Income (loss) from discontinued operations, net of tax | $ | 735 | $ | (418) | |||||||
Operating cash flows of discontinued operations | $ | — | $ | 31,117 | |||||||
Investing cash flows of discontinued operations | $ | — | $ | (4,858) | |||||||
Financing cash flows of discontinued operations | $ | — | $ | (13,559) |
March 31, 2022 | December 31, 2021 | ||||||||||
Assets of Discontinued Operations | |||||||||||
Operating lease right-of-use assets, net | $ | 6,573 | $ | 6,164 | |||||||
Total assets held for sale | $ | 6,573 | $ | 6,164 |
Liabilities of Discontinued Operations | |||||||||||
Operating leases, including current portion | $ | 11,663 | $ | 10,849 | |||||||
Total liabilities held for sale | $ | 11,663 | $ | 10,849 |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Revenues | |||||||||||
Mexico | $ | 142,549 | $ | 135,397 | |||||||
Peru | 65,404 | 57,498 | |||||||||
Corporate | 1,610 | 1,806 | |||||||||
Revenues | $ | 209,563 | $ | 194,701 | |||||||
Adjusted EBITDA of reportable segments | |||||||||||
Mexico | $ | 36,951 | $ | 17,269 | |||||||
Peru | 3,829 | 11,594 | |||||||||
Total Adjusted EBITDA of reportable segments | 40,780 | 28,863 | |||||||||
Reconciling items: | |||||||||||
Corporate | (13,625) | (19,202) | |||||||||
Depreciation and amortization expense | (14,365) | (22,761) | |||||||||
Loss on impairment of assets | (144) | (56,650) | |||||||||
Share-based compensation expense | (2,762) | (1,334) | |||||||||
EiP expenses | (850) | (15,307) | |||||||||
Operating income (loss) | 9,034 | (86,391) | |||||||||
Interest income | 1,968 | 711 | |||||||||
Interest expense | (3,731) | (23,518) | |||||||||
Loss on debt extinguishment | — | (13) | |||||||||
Gain on derivatives | — | 29,330 | |||||||||
Other (expense) income, net | (1,226) | 34 | |||||||||
Foreign currency (loss) gain, net | (3,601) | 28,183 | |||||||||
Income (loss) from continuing operations before income taxes and equity in net income of affiliates | $ | 2,444 | $ | (51,664) |
March 31, 2022 | December 31, 2021 | ||||||||||
Assets | |||||||||||
Mexico | $ | 1,240,282 | $ | 1,251,791 | |||||||
Peru | 585,917 | 598,862 | |||||||||
Corporate and Discontinued Operations | 384,533 | 360,657 | |||||||||
Total assets | $ | 2,210,732 | $ | 2,211,310 |
Mexico | Peru | Total | |||||||||
Balance at December 31, 2021 | $ | 479,223 | $ | 67,572 | $ | 546,795 | |||||
Currency translation adjustments | 15,657 | 4,609 | 20,266 | ||||||||
Balance at March 31, 2022 | $ | 494,880 | $ | 72,181 | $ | 567,061 |
March 31, 2022 | December 31, 2021 | ||||||||||
Senior long-term debt: | |||||||||||
Senior Secured Credit Facility (stated maturity date October 2024) | $ | — | $ | — | |||||||
Other debt: | |||||||||||
Lines of credit | 10,816 | 10,131 | |||||||||
Notes payable and other debt | 98,966 | 102,003 | |||||||||
Total senior and other debt | 109,782 | 112,134 | |||||||||
Finance lease obligations and sale-leaseback financings | 46,095 | 45,124 | |||||||||
Total long-term debt and finance leases | 155,877 | 157,258 | |||||||||
Less: total unamortized deferred financing costs | 3,232 | 3,588 | |||||||||
Less: current portion of long-term debt and finance leases | 53,220 | 49,082 | |||||||||
Long-term debt and finance leases, less current portion | $ | 99,425 | $ | 104,588 |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Continuing operations | |||||||||||
Stock options, net of estimated forfeitures | $ | — | $ | 176 | |||||||
Restricted stock awards | 2,762 | 1,158 | |||||||||
Total continuing operations | $ | 2,762 | $ | 1,334 | |||||||
Discontinued operations | |||||||||||
Share-based compensation expense for discontinued operations | — | 242 | |||||||||
Total continuing and discontinued operations | $ | 2,762 | $ | 1,576 |
Laureate Education, Inc. Stockholders | ||||||||||||||||||||||||||
Common Stock | Additional paid-in capital | Retained Earnings (Accumulated Deficit) | Accumulated other comprehensive loss | Treasury stock at cost | Non-controlling interests | Total stockholders’ equity | ||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||||
Balance at December 31, 2021 | 180,611 | $ | 915 | $ | 2,388,783 | $ | 15,523 | $ | (520,204) | $ | (744,174) | $ | (1,285) | $ | 1,139,558 | |||||||||||
Non-cash stock compensation | — | — | 2,762 | — | — | — | — | 2,762 | ||||||||||||||||||
Purchase of treasury stock at cost | (9,485) | — | — | — | — | (112,874) | — | (112,874) | ||||||||||||||||||
Exercise of stock options and vesting of restricted stock, net of shares withheld to satisfy tax withholding | 1,379 | 6 | 10,716 | — | — | — | — | 10,722 | ||||||||||||||||||
Equitable adjustments to stock-based awards | — | — | (189) | — | — | — | — | (189) | ||||||||||||||||||
Net loss | — | — | — | (44,211) | — | — | (469) | (44,680) | ||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 | — | — | — | — | 49,573 | — | 2 | 49,575 | ||||||||||||||||||
Minimum pension liability adjustment, net of tax of $0 | — | — | — | — | 14 | — | — | 14 | ||||||||||||||||||
Balance at March 31, 2022 | 172,505 | $ | 921 | $ | 2,402,072 | $ | (28,688) | $ | (470,617) | $ | (857,048) | $ | (1,752) | $ | 1,044,888 | |||||||||||
Laureate Education, Inc. Stockholders | ||||||||||||||||||||||||||||||||
Class A Common Stock | Class B Common Stock | Additional paid-in capital | Accumulated Deficit | Accumulated other comprehensive loss | Treasury stock at cost | Non-controlling interests | Total stockholders’ equity | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
Balance at December 31, 2020 | 115,119 | $ | 548 | 90,792 | $ | 363 | $ | 3,760,029 | $ | (176,822) | $ | (941,986) | $ | (365,316) | $ | (12,882) | $ | 2,263,934 | ||||||||||||||
Beginning retained earnings adjustment | — | — | — | — | — | (101) | — | — | — | (101) | ||||||||||||||||||||||
Non-cash stock compensation | — | — | — | — | 1,576 | — | — | — | — | 1,576 | ||||||||||||||||||||||
Conversion of Class B shares to Class A shares | 17,248 | 69 | (17,248) | (69) | — | — | — | — | — | — | ||||||||||||||||||||||
Purchase of treasury stock at cost | (10,401) | — | — | — | — | — | — | (145,806) | — | (145,806) | ||||||||||||||||||||||
Exercise of stock options and vesting of restricted stock, net of shares withheld to satisfy tax withholding | 247 | 1 | — | — | (1,223) | — | — | — | — | (1,222) | ||||||||||||||||||||||
Accretion of redeemable noncontrolling interests and equity | — | — | — | — | (20) | — | — | — | — | (20) | ||||||||||||||||||||||
Net loss | — | — | — | — | — | (164,928) | — | — | (15) | (164,943) | ||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 | — | — | — | — | — | — | (59,743) | — | (18) | (59,761) | ||||||||||||||||||||||
Minimum pension liability adjustment, net of tax of $0 | — | — | — | — | — | — | (168) | — | — | (168) | ||||||||||||||||||||||
Balance at March 31, 2021 | 122,213 | $ | 618 | 73,544 | $ | 294 | $ | 3,760,362 | $ | (341,851) | $ | (1,001,897) | $ | (511,122) | $ | (12,915) | $ | 1,893,489 | ||||||||||||||
March 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
Laureate Education, Inc. | Noncontrolling Interests | Total | Laureate Education, Inc. | Noncontrolling Interests | Total | ||||||||||||||||||
Foreign currency translation adjustment | $ | (479,899) | $ | 948 | $ | (478,951) | $ | (529,472) | $ | 946 | $ | (528,526) | |||||||||||
Unrealized gain on derivatives | 10,416 | — | 10,416 | 10,416 | — | 10,416 | |||||||||||||||||
Minimum pension liability adjustment | (1,134) | — | (1,134) | (1,148) | — | (1,148) | |||||||||||||||||
Accumulated other comprehensive loss | $ | (470,617) | $ | 948 | $ | (469,669) | $ | (520,204) | $ | 946 | $ | (519,258) |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Cross currency swaps | |||||||||||
Unrealized gain | $ | — | $ | 47,624 | |||||||
Realized loss | — | (18,294) | |||||||||
Gain on derivatives, net | $ | — | $ | 29,330 |
For the three months ended March 31, | 2022 | 2021 | |||||||||
Numerator used in basic and diluted earnings (loss) per common share for continuing operations: | |||||||||||
Loss from continuing operations | $ | (45,415) | $ | (164,525) | |||||||
Loss attributable to noncontrolling interests | 469 | 24 | |||||||||
Loss from continuing operations attributable to Laureate Education, Inc. | (44,946) | (164,501) | |||||||||
Accretion of redemption value of redeemable noncontrolling interests and equity | — | (20) | |||||||||
Net loss from continuing operations for basic and diluted loss per share | $ | (44,946) | $ | (164,521) | |||||||
Numerator used in basic and diluted earnings (loss) per common share for discontinued operations: | |||||||||||
Income (loss) from discontinued operations, net of tax | $ | 735 | $ | (418) | |||||||
Loss (income) attributable to noncontrolling interests | — | (9) | |||||||||
Net income (loss) from discontinued operations for basic and diluted earnings (loss) per share | $ | 735 | $ | (427) | |||||||
Denominator used in basic and diluted earnings (loss) per common share: | |||||||||||
Basic weighted average shares outstanding | 177,995 | 200,224 | |||||||||
Basic and diluted earnings (loss) per share: | |||||||||||
Loss from continuing operations | $ | (0.25) | $ | (0.82) | |||||||
Income (loss) from discontinued operations | — | — | |||||||||
Basic and diluted loss per share | $ | (0.25) | $ | (0.82) | |||||||
For the three months ended March 31, | 2022 | 2021 | |||||||||
Stock options | 1,644 | 3,394 | |||||||||
Restricted stock units | 698 | 586 |
March 31, 2022 | March 31, 2021 | December 31, 2021 | ||||||||||||
Cash and cash equivalents | $ | 293,835 | $ | 561,330 | $ | 324,801 | ||||||||
Restricted cash | 20,607 | 106,633 | 20,774 | |||||||||||
Total Cash and cash equivalents and Restricted cash shown in the Consolidated Statements of Cash Flows | $ | 314,442 | $ | 667,963 | $ | 345,575 |
Institutions | Enrollment | 2022 YTD Revenues ($ in millions)(1) | % Contribution to 2022 YTD Revenues | |||||||||||
Mexico | 2 | 196,800 | $ | 142.5 | 68 | % | ||||||||
Peru | 3 | 208,300 | 65.4 | 32 | % | |||||||||
Total (1) | 5 | 405,100 | $ | 209.6 | 100 | % |
For the three months ended | |||||||||||
March 31, | |||||||||||
(in millions) | 2022 | 2021 | |||||||||
Revenues | $ | — | $ | 239.8 | |||||||
Share-based compensation expense | — | (0.2) | |||||||||
Other direct costs | — | (201.2) | |||||||||
Loss on impairment of assets | — | (1.1) | |||||||||
Other non-operating expense | — | (11.2) | |||||||||
Gain (loss) on sale of discontinued operations before taxes, net | 0.7 | (16.8) | |||||||||
Pretax income of discontinued operations | 0.7 | 9.2 | |||||||||
Income tax expense | — | (9.7) | |||||||||
Income (loss) from discontinued operations, net of tax | $ | 0.7 | $ | (0.4) |
% Change | |||||||||||||||||
Better/(Worse) | |||||||||||||||||
(in millions) | 2022 | 2021 | 2022 vs. 2021 | ||||||||||||||
Revenues | $ | 209.6 | $ | 194.7 | 8 | % | |||||||||||
Direct costs | 182.9 | 181.8 | (1) | % | |||||||||||||
General and administrative expenses | 17.5 | 42.6 | 59 | % | |||||||||||||
Loss on impairment of assets | 0.1 | 56.7 | 100 | % | |||||||||||||
Operating income (loss) | 9.0 | (86.4) | 110 | % | |||||||||||||
Interest expense, net of interest income | (1.8) | (22.8) | 92 | % | |||||||||||||
Other non-operating (expense) income | (4.8) | 57.5 | (108) | % | |||||||||||||
Income (loss) from continuing operations before income taxes and equity in net income of affiliates | 2.4 | (51.7) | 105 | % | |||||||||||||
Income tax expense | (48.0) | (112.9) | 57 | % | |||||||||||||
Equity in net income of affiliates, net of tax | 0.1 | — | nm | ||||||||||||||
Loss from continuing operations | (45.4) | (164.5) | 72 | % | |||||||||||||
Income (loss) from discontinued operations, net of tax | 0.7 | (0.4) | nm | ||||||||||||||
Net loss | (44.7) | (164.9) | 73 | % | |||||||||||||
Net loss attributable to noncontrolling interests | 0.5 | — | nm | ||||||||||||||
Net loss attributable to Laureate Education, Inc. | $ | (44.2) | $ | (164.9) | 73 | % |
% Change | |||||||||||||||||
Better/(Worse) | |||||||||||||||||
(in millions) | 2022 | 2021 | 2022 vs. 2021 | ||||||||||||||
Loss from continuing operations | $ | (45.4) | $ | (164.5) | 72 | % | |||||||||||
Plus: | |||||||||||||||||
Equity in net income of affiliates, net of tax | (0.1) | — | nm | ||||||||||||||
Income tax expense | 48.0 | 112.9 | 57 | % | |||||||||||||
Income (loss) from continuing operations before income taxes and equity in net income of affiliates | 2.4 | (51.7) | 105 | % | |||||||||||||
Plus: | |||||||||||||||||
Foreign currency exchange loss (gain), net | 3.6 | (28.2) | (113) | % | |||||||||||||
Other expense, net | 1.2 | — | nm | ||||||||||||||
Gain on derivatives | — | (29.3) | (100) | % | |||||||||||||
Interest expense | 3.7 | 23.5 | 84 | % | |||||||||||||
Interest income | (2.0) | (0.7) | 186 | % | |||||||||||||
Operating income (loss) | 9.0 | (86.4) | 110 | % | |||||||||||||
Plus: | |||||||||||||||||
Depreciation and amortization | 14.4 | 22.8 | 37 | % | |||||||||||||
EBITDA | 23.4 | (63.6) | 137 | % | |||||||||||||
Plus: | |||||||||||||||||
Share-based compensation expense (a) | 2.8 | 1.3 | (115) | % | |||||||||||||
Loss on impairment of assets (b) | 0.1 | 56.7 | 100 | % | |||||||||||||
EiP implementation expenses (c) | 0.9 | 15.3 | 94 | % | |||||||||||||
Adjusted EBITDA | $ | 27.2 | $ | 9.7 | 180 | % |
(in millions) | % Change | ||||||||||||||||
Better/(Worse) | |||||||||||||||||
For the three months ended March 31, | 2022 | 2021 | 2022 vs. 2021 | ||||||||||||||
Revenues: | |||||||||||||||||
Mexico | $ | 142.5 | $ | 135.4 | 5 | % | |||||||||||
Peru | 65.4 | 57.5 | 14 | % | |||||||||||||
Corporate | 1.6 | 1.8 | (11) | % | |||||||||||||
Consolidated Total Revenues | $ | 209.6 | $ | 194.7 | 8 | % | |||||||||||
Adjusted EBITDA: | |||||||||||||||||
Mexico | $ | 37.0 | $ | 17.3 | 114 | % | |||||||||||
Peru | 3.8 | 11.6 | (67) | % | |||||||||||||
Corporate | (13.6) | (19.2) | 29 | % | |||||||||||||
Consolidated Total Adjusted EBITDA | $ | 27.2 | $ | 9.7 | 180 | % |
(in millions) | Revenues | Direct Costs | Adjusted EBITDA | ||||||||||||||
March 31, 2021 | $ | 135.4 | $ | 118.1 | $ | 17.3 | |||||||||||
Organic enrollment (1) | 7.4 | ||||||||||||||||
Product mix, pricing and timing (1) | 0.6 | ||||||||||||||||
Organic constant currency | 8.0 | 1.9 | 6.1 | ||||||||||||||
Foreign exchange | (0.9) | (1.2) | 0.3 | ||||||||||||||
Other (2) | — | (13.3) | 13.3 | ||||||||||||||
March 31, 2022 | $ | 142.5 | $ | 105.5 | $ | 37.0 |
(in millions) | Revenues | Direct Costs | Adjusted EBITDA | ||||||||||||||
March 31, 2021 | $ | 57.5 | $ | 45.9 | $ | 11.6 | |||||||||||
Organic enrollment (1) | 12.2 | ||||||||||||||||
Product mix, pricing and timing (1) | (2.2) | ||||||||||||||||
Organic constant currency | 10.0 | 18.1 | (8.1) | ||||||||||||||
Foreign exchange | (2.1) | (2.4) | 0.3 | ||||||||||||||
Other | — | — | — | ||||||||||||||
March 31, 2022 | $ | 65.4 | $ | 61.6 | $ | 3.8 |
% Change | |||||||||||||||||
Better/(Worse) | |||||||||||||||||
(in millions) | 2022 | 2021 | 2022 vs. 2021 | ||||||||||||||
Revenues | $ | 1.6 | $ | 1.8 | (11) | % | |||||||||||
Expenses | 15.2 | 21.0 | 28 | % | |||||||||||||
Adjusted EBITDA | $ | (13.6) | $ | (19.2) | 29 | % |
(in millions) | 2022 | 2021 | |||||||||
Cash provided by (used in): | |||||||||||
Operating activities | $ | 53.9 | $ | 11.3 | |||||||
Investing activities | 7.9 | (1.1) | |||||||||
Financing activities | (104.1) | (199.2) | |||||||||
Effects of exchange rates changes on cash | 11.2 | (6.9) | |||||||||
Change in cash included in current assets held for sale | — | (3.5) | |||||||||
Net change in cash and cash equivalents and restricted cash | $ | (31.1) | $ | (199.3) |
Period | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs | Approximate dollar value of shares yet to be purchased under the plans or programs (1) | ||||||||||
1/1/22 - 1/31/22 | 2,119 | $ | 11.81 | 2,119 | $ | 131,714 | ||||||||
2/1/22 - 2/28/22 | 3,216 | 11.68 | 3,216 | 94,166 | ||||||||||
3/1/22 - 3/31/22 | 4,150 | 12.07 | 4,150 | 94,061 | ||||||||||
Total | 9,485 | $ | 11.88 | 9,485 | $ | 94,061 |
Exhibit No. | Exhibit Description | ||||||||||||||||
10.1†◊ | |||||||||||||||||
31.1 | |||||||||||||||||
31.2 | |||||||||||||||||
32 | |||||||||||||||||
101.INS | XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document | ||||||||||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | ||||||||||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | ||||||||||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | ||||||||||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | ||||||||||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | ||||||||||||||||
104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) | ||||||||||||||||
† | Indicates a management contract or compensatory plan or arrangement. | ||||||||||||||||
◊ | Certain identified information has been omitted from this exhibit because it is both (1) not material, and (2) is the type that the Company treats as private or confidential. |
Confidential 2 |
Sample Bonus Target | Sample Maximum Bonus | ||||
30% of base salary | 60% of base salary | ||||
$60,000 | $120,000 |
Confidential 3 |
Confidential 4 |
Component Factors | Factor Definitions | Component Weighting | Factor Weighting | |||||||||||
Business Component Factors | Adjusted EBITDA | Corporate Adjusted EBITDA results for 2022 versus a target based on the budgeted 2022 Adjusted EBITDA. | 80% | 40% | ||||||||||
Revenue | Corporate Revenue results for 2022 versus a target based on the budgeted 2022 Revenue. | 30% | ||||||||||||
New Enrollment | Corporate New Enrollment results for 2022 versus a target based on the budgeted 2022 New Enrollment. | 20% | ||||||||||||
Unlevered Free Cash Flow | Corporate Unlevered Free Cash Flow results for 2022 versus a target based on the budgeted 2022 Unlevered Free Cash Flow. | 10% | ||||||||||||
Individual Component | Individual Objectives | Individual results achieved during 2022 versus objectives as approved by management at the start of 2022. | 20% | 100% |
2022 Adjusted EBITDA Target for Corporate | |||||||||||
Performance Against Plan | Adjusted EBITDA for 2022 | % Attainment of Target | Bonus Factor | ||||||||
Maximum | [*] | 115% | 200% | ||||||||
Above Target | [*] | >100% to <115% | +6.67% for every incremental 1% in Adjusted EBITDA above target | ||||||||
Target | [*] | 100% | 100% | ||||||||
Above Threshold | [*] | 85% to <100% | -6.67% for every 1% decrease in Adjusted EBITDA below target | ||||||||
Threshold | [*] | <85% | 0% |
Confidential 5 |
2022 Revenue Target for Corporate | |||||||||||
Performance Against Plan | Revenue for 2022 | % Attainment of Target | Bonus Factor | ||||||||
Maximum | [*] | 108% | 200% | ||||||||
Above Target | [*] | >100% to <108% | +12.50% for every 1% increase in Revenue above target | ||||||||
Target | [*] | 100% | 100% | ||||||||
Above Threshold | [*] | 92% to <100% | -12.50% for every 1% decrease in Revenue below target | ||||||||
Threshold | [*] | <92% | 0% |
2022 New Enrollment Target for Corporate | |||||||||||
Performance Against Plan | New Enrollment for 2022 | % Attainment of Target | Bonus Factor | ||||||||
Maximum | [*] | 115% | 200% | ||||||||
Above Target | [*] | >100% to <115% | +6.67% for every 1% increase in New Enrollment above target | ||||||||
Target | [*] | 100% | 100% | ||||||||
Above Threshold | [*] | 85% to <100% | -6.67% for every 1% decrease in New Enrollment below target | ||||||||
Threshold | [*] | <85% | 0% |
Confidential 6 |
2022 Unlevered Free Cash Flow Target for Corporate | |||||||||||
Performance Against Plan | Unlevered Free Cash Flow for 2022 | % Attainment of Target | Bonus Factor | ||||||||
Maximum | [*] | 120% | 200% | ||||||||
Above Target | [*] | >100% to <120% | +5.00% for every incremental 1% in Unlevered Free Cash Flow above target | ||||||||
Target | [*] | 100% | 100% | ||||||||
Above Threshold | [*] | 80% to <100% | -5.00% for every 1% decrease in Unlevered Free Cash Flow below target | ||||||||
Threshold | [*] | <80% | 0% |
Confidential 7 |
Confidential 8 |
Confidential 9 |
Confidential 10 |
/s/ EILIF SERCK-HANSSEN | ||
Eilif Serck-Hanssen | ||
President and Chief Executive Officer |
/s/ RICHARD M. BUSKIRK | ||
Richard M. Buskirk | ||
Senior Vice President and Chief Financial Officer |
/s/ EILIF SERCK-HANSSEN | ||
Eilif Serck-Hanssen | ||
President and Chief Executive Officer |
/s/ RICHARD M. BUSKIRK | ||
Richard M. Buskirk | ||
Senior Vice President and Chief Financial Officer |